BARIATRIC SURGERY TECHNIQUES RECOMMENDED FOR EACH OBESE PATIENT PROFILE
DOI:
https://doi.org/10.63330/aurumpub.014-005Keywords:
Bariatric surgery, Intragastric balloon, Comorbidities, Individualized treatmentAbstract
Bariatric surgery is an effective tool for treating severe obesity, but the choice of the ideal surgical technique must be individualized, considering each patient's profile. Several factors influence this decision, such as body mass index (BMI), associated comorbidities, dietary habits, surgical history, and patient preferences. For patients with a higher BMI (above 40 kg/m²) or with severe comorbidities such as uncontrolled type 2 diabetes, Roux-en-Y gastric bypass (RYGB) is often recommended. This technique promotes significant weight loss and improves glycemic control, in addition to treating other conditions such as hypertension and dyslipidemia. Vertical gastrectomy (SG), also known as gastric sleeve, is an option for patients with a BMI between 35 and 40 kg/m² or for those who prefer a less invasive technique. SG removes part of the stomach, reducing food intake and promoting early satiety. The intragastric balloon (IGB) is a non-surgical alternative for patients with mild to moderate obesity (BMI between 30 and 35 kg/m²) or for those who need to lose weight before undergoing more complex bariatric surgery. The IGB is a temporary device that occupies space in the stomach, aiding in hunger control and adherence to a low-calorie diet. In cases of patients with refractory obesity or weight regain after bariatric surgery, revision techniques may be considered, such as converting the gastric sleeve to gastric bypass or performing new interventions to restrict gastric capacity or alter intestinal flow. The choice of surgical technique should always be discussed between the patient and the multidisciplinary team, who will assess the individual profile and expectations, in addition to providing guidance on pre- and post-operative care. It is essential to emphasize that bariatric surgery is only one part of the obesity treatment; adopting healthy habits, such as a balanced diet and regular physical activity, is essential to ensure long-term success.
Downloads
References
1. MINGRONE, G. et al. (2015). Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of na open-label, single-centre, randomised controlled trial. The Lancet.
2. NG, M. et al. (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet.
3. O’BRIEN, P.E. et al. (2002). Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or na intensive medical program: A randomized trial. Annals of Internal Medicine.
4. O’BRIEN, P.E. et al. (2019). Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the literature. Annals of Surgery.
5. PRACHAND, V.N. et al. (2010). Duodenal switch provides superior weight loss in the super-obese (BMI ≥50 kg/m²) compared with gastric bypass. Annals of Surgery.
6. ROSAENTHAL, R.J. et al. (2012). International Sleeve Gastrectomy Expert Panel Consensus Statement. Obesity Surgery.
7. RUBINO, F. et al. (2016). Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care.
8. SCHAUER, P. R. et al. (2017). Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes. The New England Journal of Medicine.
9. SHIKORA, S.A. et al. (2015). The current status of weight loss surgery, Current Opinion in Endocrinology, Diabetes and Obesity.
10. SJÖHOLM, K. et al. (2016). Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study. Diabetologia.
11. SJÖSTRÖM, L. et al. (2012). Bariatric surgery and long-term cardiovascular events. JAMA.
12. SJÖSTRÖM, L. et al. (2012). Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA.
13. SUDAN, R. et al. (2015). Morbidity, mortality, and weight loss outcomes after reoperative bariatric surgery in the USA. JAMA Surgery.
14. SUTER, M. et al. (2011). A new questionnaire for quick assessment of food tolerance after bariatric surgery. Obesity Surgery.
15. TOPART, P. et al. (2013). Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-em-Y gastric bypass in superobese patients. Surgery for Obesity and Related Diseases.
16. TREMAROLI, V., & BÄCKHED, F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature.
17. WHO (2021). Obesity and overweight. World Health Organization.
18. WORLD HEALTH ORGANIZATION. (2018). Obesity and overweight. WHO Factsheet.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Carolina Vitoratto Grunewald , Frank Thonny Almeida Menezes Dornas, Marcos Paulo Parente Araújo , Máira Santiago Pires Parente , Giovanna Galli Tonon de Mello, Vinicius Kaiser Queiroz , Marina Magalhães Siqueira Pinto de Oliveira, Pietro Giovanne de Brito Trezzi (Autor)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
